Navigation Links
Certain Drug Treatment Associated With Orofacial Clefts

A new study has confirmed the orofacial cleft (OFC) inducing effect of phenytoin, carbamazepine, oxytetracycline, and thiethylperazine//. A possible association was also suggested between OFCs and oxprenolol and amoxicillin. The study is published in the latest issue of Cleft Palate–Craniofacial Journal.

The study’s participants had been registered with the Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996. The study reviewed 1,374 cases of isolated cleft lip with or without cleft palate (CL/P), 601 cases with posterior cleft plate (PCP), 38,151 cases without birth defects used as the population controls, and 20,868 malformed controls with other defects.

Data was colleted from medical records, particularly prenatal logbooks, retrospective maternal data via a self-reported questionnaire, and home visits to non-responding mothers.

An increased risk for isolated CL/P was found in cases born to mothers treated with amoxicillin, phenytoin, oxprenolol, and thiethylperazine during the second and third month of pregnancy, which is the critical period for isolated CL/P. The risk of isolated PCP was increased in mothers treated with oxytetracycline and carbamazepine during the third and fourth month of pregnancy, the critical period for developing PCP.

Source-Newswise
SR
'"/>




Page: 1

Related medicine news :

1. Almonds As Effective As Certain Drugs In Lowering Cholesterol
2. Certain Food Beneficial for the Heart
3. Sunlight Could Be Beneficial For Certain Types Of Cancer
4. Calcium Supplements May Not Be Useful After A Certain Threshold Is Achieved
5. Small Doses Of Radiation Can Help Certain Lung Cancer Patients
6. Effects Of Certain Food Related To Single Pain Receptors
7. Spices Could Be Employed To Treat Certain Cancers
8. Certain antidepressant drugs associated with pronounced suicidal tendencies
9. Elements In Grape fruit Juice Combine Lethally with Certain Drugs, leading to potentially dangerous side effects, study.
10. John Hopkins Develops An Online Tool To Help In Research Of Certain Rare Diseases
11. Hearing May be affected by Certain Hormone Replacement Therapies
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Reflections Recovery ... now accredited by The Joint Commission for chemical dependency and behavioral health services. ... U.S. health care organizations that meet the commission’s rigorous standards. Accreditation by The ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... Clinical Plus Coating System for clients that rely on safety and cleanliness. This ... of microorganisms. , Silver has been used for centuries for its antimicrobial properties. ...
(Date:9/20/2017)... ... 2017 , ... Renal Support Network’s annual essay contest celebrates ... The theme “Describe a positive decision that you have made about your healthcare” ... one qualification— to have been diagnosed with chronic kidney disease. This year the ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/31/2017)... -- PM360,s annual Innovations Issue, published in December, ... happening across the industry. Established six years ago, this ... a comprehensive look at the newest and most exciting ... companies, startups, divisions, products, services, and strategies from the ... in this industry wants to do better—in all facets ...
Breaking Medicine Technology: